You can blame Joanna and Kristie Banks for that debacle missed opportunity.
One is just horrible at decision making and should have never been hired a few yrs ago , while one has never been in sales as a rep or manager so doesn't have any sales perspective on the market or competitive landscape.
These 2 cost Gilead min of $20 Billion in 2022 by not pushing forward an oral of the first ever approved covid agent that's been developed for 12yrs, and allowing a new unknown oral from Pfizer to enter the market first generating $23 Billion in 2022.
That oversight , hesitation, poor judgement & not anticipating the duration or mutation of covid deserves both of them to be reprimanded. Instead both will get half a million in RSUs.
One is just horrible at decision making and should have never been hired a few yrs ago , while one has never been in sales as a rep or manager so doesn't have any sales perspective on the market or competitive landscape.
These 2 cost Gilead min of $20 Billion in 2022 by not pushing forward an oral of the first ever approved covid agent that's been developed for 12yrs, and allowing a new unknown oral from Pfizer to enter the market first generating $23 Billion in 2022.
That oversight , hesitation, poor judgement & not anticipating the duration or mutation of covid deserves both of them to be reprimanded. Instead both will get half a million in RSUs.